Mirxes Holding Co Ltd

02629

Company Profile

  • Business description

    Mirxes Holding Co Ltd is a miRNA technology company that is making diagnostic solutions for the screening of diseases accessible across its key markets in Asia, including Singapore and China. It has one Core Product (namely, GASTROClearTM), two other commercialized products (namely, LUNGClearTM and FortitudeTM), and six product candidates at the pre-clinical stage, as illustrated in the chart below. GASTROClearTM, its Core Product, is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. The company generates the majority of its revenue from Singapore.

  • Contact

    2 Tukang Innovation Grove
    No. 09-02 JTC MedTech Hub
    Singapore618305
    SGP

    T: +65 68162931

    https://www.mirxes.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    347

Stocks News & Analysis

stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
stocks

Why I dislike dividend stocks

If you need income then buying dividend stocks makes perfect sense. But if you don’t then it makes little sense because it’s likely to limit building real wealth. Here’s what you should do instead.
stocks

Chart of the Week: Ramsay Health Care margins to rebound

Charts from our latest stock pitch for Ramsay Health Care show a clear path to improved profitability.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,292.8045.50-0.49%
CAC 408,188.59111.591.38%
DAX 4024,272.1990.820.38%
Dow JONES (US)45,952.24301.07-0.65%
FTSE 1009,436.0911.340.12%
HKSE25,473.09415.42-1.60%
NASDAQ22,562.54107.54-0.47%
Nikkei 22547,640.98636.76-1.32%
NZX 50 Index13,289.2199.89-0.75%
S&P 5006,629.0741.99-0.63%
S&P/ASX 2008,995.4034.60-0.38%
SSE Composite Index3,877.2039.03-1.00%

Market Movers